Search results for "EJECTION FRACTION"

showing 10 items of 378 documents

Effect of ischaemic preconditioning, cardiopulmonary bypass and myocardial ischaemic/reperfusion on free radical generation in CABG patients.

2001

Abstract Objective: To investigate the free radicals (FR) generation after ischaemic preconditioning and cardiopulmonary bypass and during reperfusion in CABG patients, and the role of ischaemic preconditioning. Methods: Forty-three CABG patients were randomised into an ischaemic preconditioning and a control group. The protocol for ischaemic preconditioning was two cycles of 2-min ischaemia followed by 3-min reperfusion. Free radicals were measured using electron spin resonance spectroscopy. Global and right heart functions were collected. Results: The free radicals generation in coronary sinus blood in the ischaemic preconditioning group was 9.7 and 16.6% after the ischaemic preconditioni…

Malemedicine.medical_specialtyFree RadicalsIschemiaCardiac indexMyocardial IschemiaHemodynamicsVentricular Function Leftlaw.inventionRight ventricular ejection fractionPostoperative ComplicationslawInternal medicineCardiopulmonary bypassmedicineHumansRadiology Nuclear Medicine and imagingCardiac OutputCoronary Artery BypassCoronary sinusAgedMyocardial StunningCardiopulmonary Bypassbusiness.industryStunningHemodynamicsStroke VolumeMiddle Agedmedicine.diseaseAnesthesiaIschemic Preconditioning MyocardialCardiologyIschemic preconditioningSurgeryFemaleCardiology and Cardiovascular MedicinebusinessCardiovascular surgery (London, England)
researchProduct

Prognostic value of exercise myocardial scintigraphy in patients with coronary chronic total occlusions.

2010

Objectives: To evaluate the prognostic value of exercise myocardial scintigraphy in patients undergoing incomplete revascularization by means of percutaneous coronary intervention (PCI) with at least a residual chronic total occlusion (CTO) left untreated. Methods: Of 569 consecutive patients with multivessel disease undergoing myocardial scintigraphy after incomplete revascularization by PCI between March 1997 and December 2004, 126 (79% male, 64 ± 10 years) with ≥ 1 residual CTO fulfilled the eligibility criteria and entered in the study. Hard events defined as cardiac death and myocardial infarction, soft events defined as incidence of unstable angina and PCI procedures, and their compos…

Malemedicine.medical_specialtyHeart Diseasesmedicine.medical_treatmentCoronary AngiographyRisk AssessmentMyocardial perfusion imagingOrganophosphorus CompoundsPredictive Value of TestsInternal medicineCoronary CirculationmedicinescintigraphyHumanscto.Radiology Nuclear Medicine and imagingMyocardial infarctionAngioplasty Balloon CoronaryAgedProportional Hazards ModelsTomography Emission-Computed Single-PhotonEjection fractionexercisemedicine.diagnostic_testbusiness.industryUnstable anginaIncidence (epidemiology)Myocardial Perfusion ImagingPercutaneous coronary interventionmyocardialOrganotechnetium CompoundsMiddle Agedmedicine.diseasePrognosisCoronary OcclusionConventional PCIChronic DiseaseCardiologyExercise TestFemaleRadiopharmaceuticalsCardiology and Cardiovascular MedicinebusinessPerfusionFollow-Up StudiesJournal of interventional cardiology
researchProduct

Clinical Benefit of Cardiac Resynchronization Therapy With a Defibrillator in Patients With an Ejection Fraction > 35% Estimated by Cardiac Magnet…

2014

A B S T R A C T Introduction and objectives: Cardiac resynchronization therapy with a defibrillator prolongs survival and improves quality of life in advanced heart failure. Traditionally, patients with ejection fraction > 35 estimated by echocardiography have been excluded. We assessed the prognostic impact of this therapy in a group of patients with severely depressed systolic function as assessed by echocardiography but with an ejection fraction > 35% as assessed by cardiac magnetic resonance. Methods: We analyzed consecutive patients admitted for decompensated heart failure between 2004 and 2011. The patients were in functional class II-IV, with a QRS to 120 ms, ejection fraction 35% es…

Malemedicine.medical_specialtyHeart Ventriclesmedicine.medical_treatmentCardiac resynchronization therapyMagnetic Resonance Imaging CineCardiac Resynchronization TherapyNecrosisQRS complexQuality of lifeInternal medicinemedicineHumansAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryMyocardiumStroke VolumeMagnetic resonance imagingGeneral Medicinemedicine.diseaseImplantable cardioverter-defibrillatorDefibrillators ImplantableHeart failureVentricular FibrillationTachycardia VentricularCardiologyFemalebusinessCardiac magnetic resonanceRevista Española de Cardiología (English Edition)
researchProduct

Chronic pharmacological treatment in takotsubo cardiomyopathy.

2008

Abstract Background Takotsubo cardiomyopathy is a disorder that has been appreciated only recently. In most of reported cases, this syndrome mimes an acute myocardial infarction. Till this moment no data are available from literature about the treatment in the acute phase of this disease. Aim of the study In our multicentric experience we have retrospectively looked at the benefits of a treatment with ACE-inhibitors, beta-blockers, Aspirin and calcium channels blockers, started until the early phases of the disease and continued for 30 days, in 36 patients affected by Takotsubo cardiomyopathy. We chose as endpoint of the study the efficacy of the used drug in improving left ventricular myoc…

Malemedicine.medical_specialtyHeart diseaseAdrenergic beta-AntagonistsCardiomyopathyAngiotensin-Converting Enzyme InhibitorsTakotsubo CardiomyopathyInternal medicineMedicineHumansMyocardial infarctionAgedRetrospective StudiesAspirinEjection fractionAspirinbusiness.industryRetrospective cohort studymedicine.diseaseCalcium Channel BlockersSurgeryTreatment OutcomeACE inhibitorCardiologyFemaleDifferential diagnosisCardiology and Cardiovascular Medicinebusinessmedicine.drugInternational journal of cardiology
researchProduct

Functional Mitral Regurgitation Predicts Short-Term Adverse Events in Patients With Acute Heart Failure and Reduced Left Ventricular Ejection Fraction

2017

Functional mitral regurgitation (FMR) is a common finding in patients with acute heart failure (AHF) and reduced left ventricular ejection fraction (heart failure and reduced ejection fraction [HFrEF]). However, its clinical impact remains unclear. We aimed to evaluate the association between the severity of FMR after clinical stabilization and short-term adverse outcomes after a hospitalization for AHF. We prospectively included 938 consecutive patients with HFrEF discharged after a hospitalization for AHF, after excluding those with organic valve disease, congenital heart disease, or aortic valve disease. FMR was assessed semiquantitatively by color Doppler analysis of the regurgitant jet…

Malemedicine.medical_specialtyHeart diseaseHeart Ventricles030204 cardiovascular system & hematologyVentricular Function LeftElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointHumansIn patientProspective Studies030212 general & internal medicineAdverse effectProspective cohort studyAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryMitral Valve InsufficiencyStroke VolumePrognosismedicine.diseaseEchocardiography DopplerSurvival RateSpainHeart failureAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compe…

2011

INTRODUCTION: Hypertonic saline solution (HSS) and a moderate Na restriction plus high furosemide dose showed beneficial effects in compensated heart failure (HF), in short and long terms. The study was aimed to verify the effects of this combination on hospitalization time, readmissions and mortality in patients in New York Heart Association (NYHA) class III. METHOD: Chronic ischemic or nonischemic cardiomyopathy uncompensated patients with HF in NYHA III functional class with ejection fraction <40%, serum creatinine <2.5 mg/dL, blood urea nitrogen <60 mg/dL and reduced urinary volume were single-blind randomized in 2 groups: the first group received a 30-minute intravenous infusion of fur…

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentDiuresisPatient ReadmissionFurosemideInternal medicinemedicineHumansInfusions IntravenousAgedAged 80 and overHeart FailureSaline Solution HypertonicEjection fractionbusiness.industrySodiumFurosemideGeneral MedicineDiet Sodium-RestrictedMiddle Agedmedicine.diseaseHyepertonic saline heart failure diureticsDiuresisSurgeryHospitalizationTreatment OutcomeHeart failureCirculatory systemCardiologyTonicityFemaleDiureticbusinessmedicine.drugThe American Journal of the Medical Sciences
researchProduct

Inflammatory pathways in patients with heart failure and preserved ejection fraction.

2008

Immune activation is well established in patients with chronic heart failure and reduced ejection fraction (HF and reduced EF) and is associated with an impaired prognosis. Patients with heart failure and preserved ejection fraction (HF and preserved EF) have an impaired prognosis as well. It is not known whether they have signs of immune activation.We studied patients with HF and preserved EF (n=17, NYHA II [n=7]/III [n=10]) and patients with HF and reduced EF (n=17 NYHA II [n=1]/III [n=16]) and 20 controls. Echocardiography demonstrated preserved ejection fraction (LVEF 59+/-9%), but LV hypertrophy in patients with preserved EF as compared with patients with reduced EF (LVEF 23+/-5%). We …

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentHemodynamicsInflammationVentricular Function LeftInternal medicineNatriuretic Peptide BrainmedicineHumansIn patientReceptorAgedAged 80 and overHeart FailureInflammationEjection fractionbusiness.industryStroke VolumeMiddle Agedmedicine.diseasePeptide FragmentsCytokineHeart failureCardiologyCytokinesFemalemedicine.symptomInflammation MediatorsCardiology and Cardiovascular MedicinebusinessSignal TransductionInternational journal of cardiology
researchProduct

Impact of insulin resistance on cardiac and vascular function.

2016

Background Insulin resistance (IR), constitutes an important cardiovascular risk factor and can cause ischemic heart disease. It can lead to left ventricular dysfunction with a mechanism independent of ischemic heart disease and it is closely associated with impaired vascular function. The aim of our study was to explore the impact of IR on cardiac and vascular function, in patients with cardiovascular risk factors but angiographically undamaged coronary arteries. Methods We studied 32 patients (62.06 ± 11.19 years) with cardiovascular risk factors. All patients underwent coronary angiography, echocardiography, Doppler ultrasound of carotid arteries and laboratory tests. Exclusion criteria …

Malemedicine.medical_specialtyHomeostasis Model Assessment of Insulin Resistance (HOMA-IR)030209 endocrinology & metabolism030204 cardiovascular system & hematologyCoronary AngiographyRisk AssessmentCoronary artery disease03 medical and health sciences0302 clinical medicineInsulin resistanceVascular StiffnessRisk FactorsInternal medicinemedicineHumansPulse wave velocityAgedEjection fractionbusiness.industryvalvular heart diseaseAtrial fibrillationUltrasonography DopplerMiddle Agedmedicine.diseaseMyocardial dysfunctionCoronary arteriesCoronary artery disease (CAD)Arterial stiffnemedicine.anatomical_structureCarotid ArteriesItalyCardiovascular DiseasesEchocardiographyGlobal Longitudinal Strain (GLS)Arterial stiffnessCardiologyInsulin resistance (IR)FemaleInsulin ResistanceCardiology and Cardiovascular MedicinebusinessInternational journal of cardiology
researchProduct

Echocardiographic pulmonary artery pressure estimation and heart failure rehospitalization burden in patients with acute heart failure

2017

Abstract Pulmonary hypertension (PH) is a strong predictor of mortality in patients with heart failure (HF). However, the relationship between PH, through echocardiographic pulmonary artery pressure (PASP) estimation, and the risk of HF rehospitalizations remains unclear. Methods We prospectively included 2343 consecutive patients discharged for acute heart failure (AHF). PH was estimated by echocardiography through PASP determination during the index admission. Patients were categorized as follows across PASP: non-measurable, normal (≤35mmHg), mild (36–45mmHg), moderate (46–60mmHg), or severe PH (>60mmHg). Negative binomial regression method was used to evaluate the association between PAS…

Malemedicine.medical_specialtyHypertension PulmonaryPulmonary Artery030204 cardiovascular system & hematologyPatient ReadmissionCohort Studies03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicinemedicine.arteryHumansMedicineProspective Studies030212 general & internal medicineProspective cohort studyAgedAged 80 and overHeart FailureEjection fractionbusiness.industryMiddle Agedmedicine.diseasePulmonary hypertensionConfidence intervalEchocardiographyHeart failureAcute DiseasePulmonary arteryCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesCohort studyInternational Journal of Cardiology
researchProduct

Troponin I/ejection fraction ratio: A new index to differentiate Takotsubo cardiomyopathy from myocardial infarction

2015

– Transient hypokinesis, akinesis, or dyskinesis of the left ventricular mid-segments with or without apical involvement; the regional wall motion abnormalities extend beyond a single epicardial vascular distribution; a stressful trigger is often, but not always, present; – Absence of obstructive coronary disease or angiographic evidence of acute plaque rupture; – New ECG abnormalities (either ST-segment elevation and/or T wave inversion) or modest elevation in cardiac troponin; and – Absence of pheochromocytoma or myocarditis.

Malemedicine.medical_specialtyLeft ventricular ejection fractionMyocarditisCardiomyopathyMyocardial InfarctionAcute myocardial infarctionPheochromocytomaDiagnosis DifferentialElectrocardiographyTakotsubo CardiomyopathyT waveInternal medicineTroponin ImedicineHumansMyocardial infarctionAgedEjection fractionbiologybusiness.industryMedicine (all)Troponin IStroke VolumeMiddle Agedmedicine.diseaseTroponinSettore MED/11 - Malattie Dell'Apparato CardiovascolareTroponinbiology.proteinCardiologyFemalebusinessCardiology and Cardiovascular MedicineHuman
researchProduct